Meta-Analysis of Risks for Short-Term Readmission in Patients With Heart Failure

This investigation sought to quantify the risk factors for short-term readmission in patients with heart failure (HF). Electronic databases were systematically searched for studies reporting relative risk, odds ratio, and hazard ratio for the combined primary outcome of all-cause hospital readmission or all-cause mortality ≤90 days from discharge of patients with HF. Clinical characteristics, study design, type and incidence of outcome, univariable effect sizes for each risk factor, and their associated 95% confidence intervals were extracted. Each univariable effect size was pooled and computed in a separate meta-analysis using random-effects models weighted by inverse variance. The frequency of significance of each risk factor in multivariable models was also assessed to confirm their independence. Sixty-nine studies (2,038,524 patients) were included and 144 factors were reported, including 32 reported more than twice. The significant associations of the combined primary outcome were chronic lung disease, chronic kidney disease, atherosclerotic vascular disease (peripheral, coronary, and cerebrovascular), diabetes, anemia, lower systolic blood pressure, previous admission, multidisciplinary treatment, and use of beta-blockade and angiotensin-converting enzyme inhibition or angiotensin receptor blockade. In multivariable analyses, most of these variables remained independently associated with the combined primary outcome. However, age, male gender, black race, hypertension, dyslipidemia, smoking, atrial fibrillation, cancer, and uses of diuretics, aldosterone antagonists, and digoxin were not significant. In conclusion, noncardiovascular co-morbidities, poor physical condition, history of admission, and failure to use evidence-based medication are more strongly associated with 90-day readmission or death than standard risks in patients with HF.

The American Journal of Cardiology

http://dx.doi.org/10.1016/j.amjcard.2015.11.048

A cura di Calogero Calcullo

Rubriche

BANDO COMPONENTE COMITATO SCIENTFICO

CANDIDATURA A COMPONENTE DEL COMITATO SCIENTIFICO INTERNO. A breve, data termine presentazione domanda. Inviare la domanda compilata a: segreteria.direzione@ancecardio.it Scarica il bando Scarica il fax simile...

L’ INTELLIGENZA ARTIFICIALE IN CARDIOLOGIA

MAURIZIO BARONI Bologna, cardiologo libero professionista, segretario regionale ANCE Emilia-Romagna, vicepresidente regionale SIT Emilia-RomagnaScarica articolo L’intelligenza artificiale (IA) sta entrando sempre di più nell’ambito medico tanto da modificare e...

DETERMINAZIONE REGIONE LAZIO

Iscrizione dell’Ente A.N.C.E. - CARDIOLOGIA ITALIANA DEL TERRITORIO (rep. n. 142031, CF 94013530483) nella sezione ALTRI ENTI DEL TERZO SETTORE ai sensi dell?articolo 22 del D. Lgs. del 3 luglio 2017 n. 117 e dell?articolo 16 del Decreto Ministeriale n. 106 del...

Lo studio ASSURE DES

Giuseppe Strano Cardiologo Specialista Ambulatoriale c/o ASL Brindisi Segretario Provinciale ANCE, Brindisi Scarica articolo Le attuali linee guida raccomandano di rimandare la chirurgia elettiva per almeno 6 o 12 mesi dopo un intervento coronarico percutaneo, di...

FIBRILLAZIONE ATRIALE E SPORT

MAURIZIO BARONI Segretario Regionale ANCE Emilia RomagnaScarica articolo La fibrillazione atriale è una delle aritmie più frequenti e clinicamente significative; colpisce infatti un numero elevato di persone prevalentemente in età avanzata (fino al 10 % della...